These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38450163)

  • 1. Postbiotics in colorectal cancer: intervention mechanisms and perspectives.
    Xie W; Zhong YS; Li XJ; Kang YK; Peng QY; Ying HZ
    Front Microbiol; 2024; 15():1360225. PubMed ID: 38450163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Crucial Roles of Diet, Microbiota, and Postbiotics in Colorectal Cancer.
    Kuru-Yaşar R; Üstün-Aytekin Ö
    Curr Nutr Rep; 2024 Jun; 13(2):126-151. PubMed ID: 38483752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
    Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
    World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease.
    Kavita ; Om H; Chand U; Kushawaha PK
    Microbiol Res; 2024 Feb; 279():127550. PubMed ID: 38016379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment.
    Rad AH; Aghebati-Maleki L; Kafil HS; Abbasi A
    Crit Rev Food Sci Nutr; 2021; 61(11):1787-1803. PubMed ID: 32410512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postbiotics and Their Health Modulatory Biomolecules.
    Scott E; De Paepe K; Van de Wiele T
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of Colorectal cancer in AOM/DSS murine model.
    Tian TT; Chen G; Sun K; Wang XY; Liu Y; Wang FQ; Yang B; Liu J; Han JY; Tang DX
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113193. PubMed ID: 39368132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postbiotics versus probiotics in early-onset colorectal cancer.
    Feizi H; Plotnikov A; Rezaee MA; Ganbarov K; Kamounah FS; Nikitin S; Kadkhoda H; Gholizadeh P; Pagliano P; Kafil HS
    Crit Rev Food Sci Nutr; 2024; 64(11):3573-3582. PubMed ID: 36250549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies.
    Ha S; Zhang X; Yu J
    Chin Med J (Engl); 2024 Jan; 137(1):8-20. PubMed ID: 38031348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postbiotics in oncology: science or science fiction?
    Kudra A; Kaźmierczak-Siedlecka K; Sobocki BK; Muszyński D; Połom J; Carbone L; Marano L; Roviello F; Kalinowski L; Stachowska E
    Front Microbiol; 2023; 14():1182547. PubMed ID: 37608943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Metabolite Dysbiosis and Colorectal Cancer.
    Niekamp P; Kim CH
    Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances and potentiality of postbiotics in the food industry: Composition, inactivation methods, current applications in metabolic syndrome, and future trends.
    Zhong Y; Wang T; Luo R; Liu J; Jin R; Peng X
    Crit Rev Food Sci Nutr; 2024; 64(17):5768-5792. PubMed ID: 36537328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postbiotics as potential new therapeutic agents for sepsis.
    Lou X; Xue J; Shao R; Mo C; Wang F; Chen G
    Burns Trauma; 2023; 11():tkad022. PubMed ID: 37334140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota alterations associated with vascular diseases: postbiotics as a next-generation magic bullet for gut-vascular axis.
    Flori L; Benedetti G; Martelli A; Calderone V
    Pharmacol Res; 2024 Sep; 207():107334. PubMed ID: 39103131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial insights into postbiotics against colorectal cancer.
    Song D; Wang X; Ma Y; Liu NN; Wang H
    Front Nutr; 2023; 10():1111872. PubMed ID: 36969804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of paraprobiotics and postbiotics to modulate the immune system: A Review.
    Mehta JP; Ayakar S; Singhal RS
    Microbiol Res; 2023 Oct; 275():127449. PubMed ID: 37454427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial Metabolites, Postbiotics, and Intestinal Epithelial Function.
    Mayorgas A; Dotti I; Salas A
    Mol Nutr Food Res; 2021 Mar; 65(5):e2000188. PubMed ID: 32992407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.